» Articles » PMID: 20133448

Deletion of IGF-I Receptor (IGF-IR) in Primary Osteoblasts Reduces GH-induced STAT5 Signaling

Overview
Journal Mol Endocrinol
Date 2010 Feb 6
PMID 20133448
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

GH promotes longitudinal growth and regulates multiple cellular functions in humans and animals. GH signals by binding to GH receptor (GHR) to activate the tyrosine kinase, Janus kinase 2 (JAK2), and downstream pathways including signal transducer and activator of transcription 5 (STAT5), thereby regulating expression of genes including IGF-I. GH exerts effects both directly and via IGF-I, which signals by activating the IGF-I receptor (IGF-IR). IGF-IR is a cell surface receptor that contains intrinsic tyrosine kinase activity within its intracellular domain. In this study, we examined the potential role of IGF-IR in facilitating GH-induced signal transduction, using mouse primary calvarial osteoblasts with Lox-P sites flanking both IGF-IR alleles. These cells respond to both GH and IGF-I and in vitro infection with an adenovirus that drives expression of Cre recombinase (Ad-Cre) dramatically reduces IGF-IR abundance without affecting the abundance of GHR, JAK2, STAT5, or ERK. Notably, infection with Ad-Cre, but not a control adenovirus, markedly inhibited acute GH-induced STAT5 activity (more than doubling the ED(50) and reducing the maximum activity by nearly 50%), while sparing GH-induced ERK activity, and markedly inhibited GH-induced transactivation of a STAT5-dependent luciferase reporter. The effect of Ad-Cre on GH signaling was specific, as platelet-derived growth factor-induced signaling was unaffected by Ad-Cre-mediated reduction of IGF-IR. Ad-Cre-mediated inhibition of GH signaling was reversed by adenoviral reexpression of IGF-IR, but not by infection with an adenovirus that drives expression of a hemagglutination-tagged somatostatin receptor, which drives expression of the unrelated somatostatin receptor, and Ad-Cre infection of nonfloxed osteoblasts did not affect GH signaling. Notably, infection with an adenovirus encoding a C-terminally truncated IGF-IR that lacks the tyrosine kinase domain partially rescued both acute GH-induced STAT5 activity and GH-induced IGF-I gene expression in cells in which endogenous IGF-IR was reduced. These data, in concert with our earlier findings that GH induces a GHR-JAK2-IGF-IR complex, suggest a novel function for IGF-IR. In addition to its role as a key IGF-I signal transducer, this receptor may directly facilitate acute GH signaling. The implications of these findings are discussed.

Citing Articles

Classical and novel GH receptor signaling pathways.

Frank S Mol Cell Endocrinol. 2020; 518:110999.

PMID: 32835785 PMC: 7799394. DOI: 10.1016/j.mce.2020.110999.


Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity.

DiToro D, Harbour S, Bando J, Benavides G, Witte S, Laufer V Immunity. 2020; 52(4):650-667.e10.

PMID: 32294406 PMC: 8078727. DOI: 10.1016/j.immuni.2020.03.013.


Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

Zhang Y, Gc S, Patel S, Liu Y, Paterson A, Kappes J Mol Cell Endocrinol. 2019; 492:110445.

PMID: 31100495 PMC: 6613819. DOI: 10.1016/j.mce.2019.05.004.


Growth Hormone Induces Colon DNA Damage Independent of IGF-1.

Chesnokova V, Zonis S, Barrett R, Gleeson J, Melmed S Endocrinology. 2019; 160(6):1439-1447.

PMID: 31002310 PMC: 6530523. DOI: 10.1210/en.2019-00132.


Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.

Zhou Y, Zhang Z, Wang N, Chen J, Zhang X, Guo M Cell Death Dis. 2018; 9(4):429.

PMID: 29559623 PMC: 5861121. DOI: 10.1038/s41419-018-0457-5.


References
1.
Yakar S, Liu J, STANNARD B, Butler A, Accili D, Sauer B . Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A. 1999; 96(13):7324-9. PMC: 22084. DOI: 10.1073/pnas.96.13.7324. View

2.
Sotiropoulos A, Perrot-Applanat M, Dinerstein H, Pallier A, Postel-Vinay M, Finidori J . Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology. 1994; 135(4):1292-8. DOI: 10.1210/endo.135.4.7925092. View

3.
Morales O, Lindgren U, Haldosen L . Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells. J Bone Miner Res. 2000; 15(11):2284-90. DOI: 10.1359/jbmr.2000.15.11.2284. View

4.
Kim S, Houtman J, Jiang J, Ruppert J, Bertics P, Frank S . Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts. J Biol Chem. 1999; 274(50):36015-24. DOI: 10.1074/jbc.274.50.36015. View

5.
Slootweg M, van Buul-Offers S, HERRMANN-ERLEE M, van der Meer J, Duursma S . Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. J Endocrinol. 1988; 116(3):R11-3. DOI: 10.1677/joe.0.116r011. View